Skip to main content

Table 5 Secondary outcome measures for saint george's respiratory questionnaire (sgrq): Change of total symptom score, symptom score, activity score and impact score During 6 months of treatment with cineole or placebo*

From: Concomitant therapy with Cineole (Eucalyptole) reduces exacerbations in COPD: A placebo-controlled double-blind trial

SGRQ SCORES

PLACEBO

CINEOLE

P VALUE †

 

BASE LINE

6 MONTHS

BASE LINE

6 MONTHS

 

Symptom score

57.4 ± 20.2

48.5 ± 24.9

57.3 ± 20.4

43.8 ± 24.3

0.0224

Activity score

53.4 ± 21.9

50.0 ± 24.8

52.1 ± 20.5

43.5 ± 22.4

0.2032

Impact score

37.2 ± 20.9

33.9 ± 23.3

35.8 ± 20.2

27.4 ± 19.2

0.1126

TOTAL SYMPTOM SCORE

45.6 ± 18.9

41.3 ± 22.5

44.4 ± 17.8

34.5 ± 18.9

0.0630

  1. * Plus – minus values are means ± SD. Lower scores on the scores indicate higher quality of life.
  2. † P-Values are for the comparison of the changes in scores from base line to 6 months treatment between the two groups.